Crescent Capital BDC, Inc. logo

Crescent Capital BDC, Inc. (CCAP)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS)
$
8. 90
-0.23
-2.5192%
$
334.93M Market Cap
10.64 P/E Ratio
1.25% Div Yield
215,780 Volume
2.21 Eps
$ 9.13
Previous Close
Add Transaction
Day Range
8.89 9.16
Year Range
8.86 15.18
Want to track CCAP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CCAP closed today lower at $8.9, a decrease of -2.5192% from yesterday's close, completing a monthly decrease of -16.0377% or -$1.7. Over the past 12 months, CCAP stock lost -36.5645%.
CCAP pays dividends to its shareholders, with the most recent payment made on Yesterday at 12:00 AM. The next announced payment will be in In 1 month on Dec 15, 2026 for a total of $0.03.
The last earnings report, released on May 13, 2026, missed the consensus estimates by -0.4141%. On average, the company has fell short of earnings expectations by -0.288%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on NASDAQ (NMS) (USD).

CCAP Chart

Crescent Capital: Coverage Restoration, Fee Reduction And Rate Hikes Are Catalysts

Crescent Capital: Coverage Restoration, Fee Reduction And Rate Hikes Are Catalysts

Crescent Capital is upgraded from ‘Buy' to ‘Strong Buy' due to improved dividend coverage and a compelling valuation. CCAP's 19% dividend cut enhanced coverage, with Q2 net investment income covering the dividend at 106%. Management lowered both management and incentive fees, further supporting future dividend stability and income profile.

Seekingalpha | 3 weeks ago
Crescent Capital BDC, Inc. (CCAP) Q2 2026 Earnings Call Transcript

Crescent Capital BDC, Inc. (CCAP) Q2 2026 Earnings Call Transcript

Crescent Capital BDC, Inc. (CCAP) Q2 2026 Earnings Call Transcript

Seekingalpha | 2 months ago
Crescent Capital BDC (CCAP) Misses Q2 Earnings and Revenue Estimates

Crescent Capital BDC (CCAP) Misses Q2 Earnings and Revenue Estimates

Crescent Capital BDC (CCAP) came out with quarterly earnings of $0.36 per share, missing the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.46 per share a year ago.

Zacks | 2 months ago

Crescent Capital BDC, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
BZ
Brandon Zatopek Commonwealth Equity Services LLC
18,765 $204,920 $168,134.4 -$36,785.6 -17.95%
MLG
Michael L. Gravelle Fidelity National Financial Inc.
4.21M $51.6M $37.62M -$13.98M -27.1%
Bulldog Investors
Bulldog Investors Bulldog Investors LLP
437,177 $6.19M $3.98M -$2.2M -35.59%
PF
Phillip Fitzsimmons Hennion & Walsh Asset Management Inc.
70,716 $1.01M $648,112.14 -$366,883.57 -36.15%
Thomas Herbert
Thomas Herbert VPR Management LLC
9,000 $127,180 $82,305 -$44,875 -35.28%

Crescent Capital BDC, Inc. (CCAP) FAQ

What is the stock price today?

The current price is $8.90.

On which exchange is it traded?

Crescent Capital BDC, Inc. is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is CCAP.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.25%.

What is its market cap?

As of today, the market cap is 334.93M.

Has Crescent Capital BDC, Inc. ever had a stock split?

No, there has never been a stock split.

Crescent Capital BDC, Inc. Profile

Banks Industry
Financials Sector
Jason A. Breaux CEO
NASDAQ (NMS) Exchange
225655109 CUSIP
US Country
250 Employees
30 Nov 2026 Last Dividend
- Last Split
3 Feb 2020 IPO Date

Overview

Crescent Capital BDC, Inc. operates as a Business Development Company (BDC) focused on providing financial solutions to middle-market companies across the United States. The firm is tailored towards private equity buyouts and loan funds, positioning itself as a crucial player for businesses seeking direct investments. Crescent Capital BDC aims to drive growth and value creation by leveraging its expertise in the middle market, a sector known for its significant contribution to the U.S. economy but often underserved by traditional banking institutions.

Products and Services

  • Private Equity Buyouts

    Crescent Capital BDC provides comprehensive support for private equity buyouts, offering strategic investments to companies seeking to transition ownership, pursue growth opportunities, or undergo significant restructuring. This service is designed for enterprises at critical junctures of their development, where seasoned investment partners can add substantial value.

  • Loan Funds

    Specializing in directly investing, Crescent Capital BDC extends loan funds to middle-market businesses. These loan products are tailored to meet the financial requirements of companies in this segment, providing them with the necessary capital to fuel expansion, refinance existing debt, or support day-to-day operations. A focus on direct investment ensures that businesses have a reliable funding source with expertise in navigating the complexities of the middle market.

Contact Information

Address: 11100 Santa Monica Boulevard
Phone: (310) 235-5900